Apheresis

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Novartis Pharma AG Commercial
    PELACARSEN
    2023-503611-16-00 1 country 2023 n=60
    Ended
  • Novartis Pharma AG Commercial
    PELACARSEN
    2023-508324-35-00 1 country 2022 n=51
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 2 Phase III 0
New trials by year
2022
1
2023
1
← All indication landscapes